Article
Dexmedetomidine impacts IDO1 and CHRM3 in breast cancer
2024-02-07
Abstract excerpt
<h4>Background: </h4> As the most invasive breast cancer (BrCa), triple-negative BrCa (TNBC) has the worst survival. The use of dexmedetomidine potentially affected BrCa surgery and dexmedetomidine was reported to have direct effects on TNBC cells. The objective of this study is to explore the mechanisms underlying the effect of dexmedetomidine on TNBC. Methods Dexmedetomidine targets were predicted using The Can...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b3ac525b-af9d-5c13-bb0d-8fe35aade7c9
- DOI
- 10.21203/rs.3.rs-3934535/v1
